Constellate Proteomics is developing a compact device that aims to transform how protein-based drugs are analysed during development and production.

To empower scientists in the analysis of their own data sets, and open data; by giving them access to powerful, intuitive, web-based data analytics tools.

Developing the next generation of nanomedicines

Detecting cancer recurrence before it’s too late

CytoBas is transforming allergy diagnostics with a novel multiplex flow cytometry assay that offers rapid, accurate, and functionally relevant results. Unlike traditional tests that rely on serum IgE or skin reactions, CytoBas directly detects allergen-specific IgE bound to basophils—the immune cells that trigger allergic responses. 

D4 Diagnostics has developed D4BST to quantify the number of immune cells in tumors prior to treatment. D4BST is an assay for accurate, fast and reliable quantification of B-, Switched B- and T cells in traces of DNA from tumors or its surrounding environment.

DEPREDICT uses cutting-edge machine learning and neuroimaging MRI to address the urgent need for decision support in treating depression, a global health crisis impacting over 40 million Europeans annually.

Assisting people to make diet-related lifestyle changes through gaming

A new class of dual drugs for cancer treatment which are well tolerated and can be taken orally

EdgeLeap is an information technology company pushing AI to its limits to surface business relevant insights from continuous stream of world’s information, helping their clients can make intelligent strategic decisions every day.